Antibodies may predict transplant rejection risk

June 19, 2018 by Anna Williams, Northwestern University
Credit: CC0 Public Domain

The presence of certain antibodies in patients may suggest a higher risk of transplant rejection across multiple organ types, including the kidney, liver, heart and lungs, according to a new study published in PLOS Medicine.

"The field of transplantation will benefit from this study by being able to better determine the risk of in some ," said co-author John Friedewald, MD, professor of Medicine in the Division of Nephrology and Hypertension and of Surgery in the Division of Organ Transplantation.

Despite immunosuppressive therapies, organ rejection remains a significant challenge in transplantation, with thousands of transplanted organs failing each year.

In previous studies, a group of antibodies called anti-human leukocyte antigen donor-specific antibodies (anti-HLA DSAs) have been increasingly recognized as an important contributor to rejection and long-term failure of transplanted organs, especially of kidneys. However, it has remained unclear whether anti-HLA DSAs are associated with poor outcomes in transplantation consistently across patient populations, and across multiple organ types.

In the current study, investigators performed a meta-analysis of 37 publications, which included data from close to 8,000 patients who had received either kidney, liver, heart or lung transplants.

The scientists discovered that organ recipients with circulating complement-activating anti-HLA DSAs had a three-fold increased risk of long-term loss—compared to patients without anti-HLA DSAs or with those anti-HLA DSAs that were considered non-complement-activating. Beyond survival, the antibodies were also associated with an increased risk of organ rejection.

The findings were consistent across all organ types and across different tests and times of evaluation.

Overall, the results suggest that complement-activating anti-HLA DSAs could potentially serve as a biomarker to stratify the risk of and failure in transplant patients.

"The clinical implication will be better donor selection and improved monitoring for people needing a transplant and after transplant," Friedewald said.

The authors also note that further research is needed in order to investigate whether the antibodies might also represent a route to therapeutics interventions. "Eventually, this could lead to improved treatment protocols for rejection," Friedewald said.

Explore further: Transplanted livers help body defend against organ rejection, study finds

More information: Antoine Bouquegneau et al. Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis, PLOS Medicine (2018). DOI: 10.1371/journal.pmed.1002572

Related Stories

Transplanted livers help body defend against organ rejection, study finds

April 18, 2018
For decades, transplant experts have observed that liver transplant recipients often need less anti-rejection medication, known as immunosuppressive drugs, than recipients of other solid organs. Similarly, when patients receive ...

Timing of anti-donor antibody responses affects the survival of kidney transplants

March 2, 2017
New research provides insights on transplant recipients' antibody responses against donor kidneys and how the timing of those responses can have important implications. The findings appear in an upcoming issue of the Journal ...

Whether the donor and recipient are male or female influences transplant rejection rates—investigators explore why

March 22, 2018
Biological sex differences can have far-reaching, clinical consequences, as illustrated by organ transplant outcomes. Men and women who receive donated organs can have different rates of transplant rejection, in some cases ...

Understanding immune system interplay to improve organ transplant success

May 31, 2018
A rare opportunity to analyse both blood and tissue samples from human transplant recipients has allowed immunology researchers at the Babraham Institute to pinpoint how an immunosuppressive drug works to prevent the production ...

Promising breakthrough for transplant patients

February 27, 2013
A team led by Dr. Marie-Josée Hébert from the University of Montreal Hospital Research Centre (CRCHUM) has discovered a new cause of organ rejection in some kidney transplant patients. Her team has identified a new class ...

Antibodies in the blood provide clues to transplant recipients' likelihood of rejection

August 20, 2015
The dominant antibody type present in the blood of transplant recipients may indicate their likelihood of experiencing organ rejection, according to a study appearing in an upcoming issue of the Journal of the American Society ...

Recommended for you

3-D-printed tracheal splints used in groundbreaking pediatric surgery

September 19, 2018
Children's Healthcare of Atlanta has performed Georgia's first-ever procedure to place 3-D-printed tracheal splints in a pediatric patient. A cross-functional team of Children's surgeons used three custom-made splints, which ...

Muscle relaxants increase risk of respiratory complications

September 18, 2018
Muscle relaxants are a necessary part of anesthesia during certain major operations. However, studies have hinted at respiratory risks connected with these drugs. POPULAR, a major prospective observational European study ...

Gunshot victims require much more blood and are more likely to die than other trauma patients

September 17, 2018
In a new analysis of data submitted to Maryland's state trauma registry from 2005 to 2017, Johns Hopkins Medicine researchers found that gunshot victims are approximately five times more likely to require blood transfusions, ...

Liver allocation system disadvantages children awaiting transplants

September 17, 2018
Children are at a considerable disadvantage when competing with adults for livers from deceased organ donors in the U.S. allocation system, a University of Pittsburgh Graduate School of Public Health-led analysis reveals ...

Taste preferences connected to success of long-term weight loss after bariatric surgery

September 16, 2018
Following Roux-en-Y gastric bypass (RYGB), a type of bariatric surgery, many patients exhibit a reduction in taste preference for sweet and fatty foods, although this effect may only be temporary, according to new research ...

New insights into what drives organ transplant rejection

September 6, 2018
When it comes to transplant rejection, some organs are far trickier than others. Some transplantable organs, such as the liver, are readily accepted by the recipient's immune system, rarely triggering an immune response and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.